In recent days, the United States Food and Drug Supervision Authority (FDA) has issued new clinical de-centric tests (also called decentralized clinical trials, DCT) guide Decentralized Clinical Trials for Drugs, Biological Products, and Devices. The guide indicates that DCT facilities are not limited to research medical centres, but can also be carried out in places such as local health-care institutions, or may visit test participants through telemedicine. Unlike traditional clinical trials...